FAST NEWS: Innocare Pharma Loss Narrows on New Drug’s Contribution
The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday that its net loss shrank by 83.5% to 64.5 million yuan ($10.1 million) last year from 2020 levels. Looking up: The company…
FAST NEWS: InnoCare Pharma Slumps after Flagship Drug Included on China’s National List
The latest: InnoCare Pharma Ltd. (9969.HK) said late Friday that its Bruton’s tyrosine kinase inhibitor Orelabrutinib, used to treat lymphoma and autoimmune diseases, has been included on the National Reimbursement…
